SUPERIOR ANTI-TUMOR EFFICACY OF CD4+CAR-T CELLS IN HEMATOLOGICAL MALIGNANCIES

被引：0

作者：

Chen, Qian ^{[1
]}

Wang, Lei ^{[1
]}

Lin, Min ^{[1
]}

Sedloev, David ^{[1
]}

Yao, Hao ^{[1
]}

Scheller, Marina ^{[1
]}

Eckstein, Volker ^{[1
]}

Hofmann, Stefanie ^{[1
]}

Han, Huixiu ^{[1
]}

Ding, Yuntian ^{[1
]}

Keib, Anna ^{[1
]}

Jiang, Genqiao ^{[1
]}

Hoffmann, Dominik ^{[1
]}

Heilmann, Hannes ^{[1
]}

Unglaub, Julia ^{[1
]}

Schmitt, Anita ^{[1
]}

Mueller-Tidow, Carsten ^{[1
]}

Schmitt, Michael ^{[1
]}

Sauer, Tim ^{[1
]}

机构：

[1] Heidelberg Univ, Heidelberg, Germany

来源：

BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期

关键词：

D O I：

暂无

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

P109

引用

页码：224 / 225

页数：2

共 50 条

[1] SUPERIOR ANTI-TUMOR EFFICACY OF CD4+CAR-T CELLS IN HEMATOLOGICAL MALIGNANCIES
Chen, Q.
Wang, L.
Sedloev, D.
Scheller, M.
Unglaub, J.
Schmitt, A.
Mueller-Tidow, C.
Schmitt, M.
Sauer, T.
HUMAN GENE THERAPY, 2023, 34 (21-22) : A14 - A14
[2] ROLE OF CAR EXPRESSION LEVELS IN THE ANTI-TUMOR EFFICACY OF CAR-T CELLS
Rodriguez-Marquez, P.
Calleja-Cervantes, M. E.
Serrano, G.
San Martin-Uriz, P.
Vilas-Zornoza, A.
Martin-Mallo, A.
Rodriguez-Diaz, S.
Martinez-Turrillas, R.
Jauregui, P.
Calvino, C.
Inoges, S.
Lopez-Diaz, de Cerio A.
Palacios-Berraquero, M. L.
Rodriguez-Otero, P.
Rifon, J.
Alfonso, A.
Lasarte, J. J.
Lozano, T.
Hernaez, M.
Rodriguez-Madoz, J. R.
Prosper, F.
HAEMATOLOGICA, 2021, 106 (10) : 58 - 59
[3] CD72 Nanobody-Based CAR-T Cells Have Potent Anti-Tumor Efficacy in B Cell Malignancies
Nix, Matthew A.
Temple, William C.
Karlon, William
Wang, Donghui
Phojanakong, Paul
Steri, Veronica
Hann, Byron
Wiita, Arun P.
BLOOD, 2021, 138
[4] CAR T cells for hematological malignancies
Savoldo, Barbara
Grover, Natalie
Dotti, Gianpietro
JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (02):
[5] Superior anti-tumor activity of GL205, an allogeneic anti-CD5 CAR-NK for treating T-cell malignancies
Jung, Miyoung
Kim, Seung Min
Lee, Eunsol
Sun, Hyunseung
Yoo, Jaeyoung
Choi, Hwi Wan
An, Subin
Cho, Sunglim
Min, Bokyung
CANCER RESEARCH, 2024, 84 (06)
[6] Safety and Anti-Tumor Activity of CD5 CAR T-Cells in Patients with Relapsed/Refractory T-Cell Malignancies
Hill, LaQuisa C.
Rouce, Rayne H.
Smith, Tyler S.
Yang, Lina
Srinivasan, Madhuwanti
Zhang, Huimin
Perconti, Silvana
Mehta, Birju
Dakhova, Olga
Randall, Josalind
Grilley, Bambi J.
Heslop, Helen E.
Brenner, Malcolm K.
Mamonkin, Maksim
BLOOD, 2019, 134
[7] Mechanism of Anti-Tumor Effect by Curcumin in Hematological Malignancies
Yi Sha
Chen Yan
CURRENT PHARMACEUTICAL ANALYSIS, 2011, 7 (02) : 120 - 124
[8] Naive CD4+T Cells Modified to Express a ROR1-Specific CAR Mediate Anti-Tumor Activity and Provide Superior Help to CD8+ROR1-CAR T Cells
Hudecek, Michael
Lupo-Stanghellini, Maria-Teresa
Kosasih, Paula
Bet, Jeannette
Paszkiewicz, Paulina
Maloney, David G.
Jensen, Michael C.
Rader, Christoph
Riddell, Stanley R.
BLOOD, 2011, 118 (21) : 294 - 294
[9] Boosting CAR T cells with anti-tumor mRNA vaccines
Chehrazi-Raffle, Alex
Budde, Lihua E.
Pal, Sumanta K.
NATURE MEDICINE, 2023, 29 (11) : 2711 - 2712
[10] Boosting CAR T cells with anti-tumor mRNA vaccines
Alex Chehrazi-Raffle
Lihua E. Budde
Sumanta K. Pal
Nature Medicine, 2023, 29 : 2711 - 2712

← 1 2 3 4 5 →